The content is available as a PDF (128.0 KB).
Footnotes
Received: 29 May 1997 / Accepted: 24 June 1997
. 1997 Oct;123(10):531–532. doi: 10.1007/s004320050100
The administration of paclitaxel without prophylaxis for the prevention of hypersensitivity reactions: is this a rationale and safe therapeutic strategy?
Maurie Markman
1
Maurie Markman
1Cleveland Clinic Cancer Center, and the Department of Hematology/Medical Oncology, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA Phone: +1 216-445-6888; Fax: +1 216-444-9464, , , , US
Find articles by Maurie Markman
1Cleveland Clinic Cancer Center, and the Department of Hematology/Medical Oncology, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA Phone: +1 216-445-6888; Fax: +1 216-444-9464, , , , US
Keywords: Paclitaxel, Therapeutic Strategy, Hypersensitivity Reaction
© Springer-Verlag Berlin Heidelberg 1997
PMCID: PMC12200074 PMID: 9393585